Inter-observer variation between pathologists in diffuse parenchymal lung disease
- PMID: 15170033
- PMCID: PMC1747021
- DOI: 10.1136/thx.2003.011734
Inter-observer variation between pathologists in diffuse parenchymal lung disease
Abstract
Background: There have been few inter-observer studies of diffuse parenchymal lung disease (DPLD), but the recent ATS/ERS consensus classification provides a basis for such a study.
Methods: A method for categorising numerically the percentage likelihood of these differential diagnoses was developed, and the diagnostic confidence of pathologists using this classification and the reproducibility of their diagnoses were assessed.
Results: The overall kappa coefficient of agreement for the first choice diagnosis was 0.38 (n = 133 biopsies), increasing to 0.43 for patients (n = 83) with multiple biopsies. Weighted kappa coefficients of agreement, quantifying the level of probability of individual diagnoses, were moderate to good (mean 0.58, range 0.40-0.75). However, in 18% of biopsy specimens the diagnosis was given with low confidence. Over 50% of inter-observer variation related to the diagnosis of non-specific interstitial pneumonia and, in particular, its distinction from usual interstitial pneumonia.
Conclusion: These results show that the ATS/ERS classification can be applied reproducibly by pathologists who evaluate DPLD routinely, and support the practice of taking multiple biopsy specimens.
Similar articles
-
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.Lancet Respir Med. 2016 Jul;4(7):557-565. doi: 10.1016/S2213-2600(16)30033-9. Epub 2016 May 11. Lancet Respir Med. 2016. PMID: 27180021
-
HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation.Thorax. 2004 Jun;59(6):506-11. doi: 10.1136/thx.2003.020396. Thorax. 2004. PMID: 15170034 Free PMC article.
-
Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.BMJ. 2017 Jun 28;357:j2813. doi: 10.1136/bmj.j2813. BMJ. 2017. PMID: 28659278 Free PMC article.
-
Lung cryobiopsies: a paradigm shift in diagnostic bronchoscopy?Respirology. 2014 Jul;19(5):645-54. doi: 10.1111/resp.12309. Epub 2014 May 26. Respirology. 2014. PMID: 24862226 Review.
-
How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop.J Clin Pathol. 2002 Dec;55(12):955-60. doi: 10.1136/jcp.55.12.955. J Clin Pathol. 2002. PMID: 12461067 Free PMC article. Review.
Cited by
-
PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery.Eur Respir Rev. 2013 Jun 1;22(128):148-52. doi: 10.1183/09059180.00000913. Eur Respir Rev. 2013. PMID: 23728868 Free PMC article. Review.
-
Idiopathic and immune-related pulmonary fibrosis: diagnostic and therapeutic challenges.Clin Transl Immunology. 2019 Nov 5;8(11):e1086. doi: 10.1002/cti2.1086. eCollection 2019. Clin Transl Immunology. 2019. PMID: 31709050 Free PMC article. Review.
-
Role of Transbronchial Cryobiopsy in Interstitial Lung Diseases: An Ongoing Tale.Am J Respir Crit Care Med. 2020 Jan 15;201(2):259-260. doi: 10.1164/rccm.201908-1559LE. Am J Respir Crit Care Med. 2020. PMID: 31535899 Free PMC article. No abstract available.
-
Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP).Eur J Radiol Open. 2021 Mar 16;8:100336. doi: 10.1016/j.ejro.2021.100336. eCollection 2021. Eur J Radiol Open. 2021. PMID: 33796637 Free PMC article. Review.
-
Classification and natural history of the idiopathic interstitial pneumonias.Proc Am Thorac Soc. 2006 Jun;3(4):285-92. doi: 10.1513/pats.200601-005TK. Proc Am Thorac Soc. 2006. PMID: 16738191 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical